腎交感神經阻斷術設備市場：依手術類型、最終用戶、地區

Renal Denervation Devices Market, By Procedure Type, By End User, By Region

出版日期: 2024年01月18日 | 出版商:

Coherent Market Insights | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023年，全球腎交感神經阻斷術裝置市場規模為9.039億美元，預計2030年將達到23.321億美元，2023年至2030年的年複合成長率為14.5%。

報告範圍		報告詳情
基準年	2022年	2023/2024年市場規模	9.039 億美元
實際資料	2018-2021	預測期	2023-2030
預測期間2023/2024 至2030/2031年年複合成長率：	14.50%	2030/2031年預測值	23.321 億美元

圖 1.腎交感神經阻斷術裝置的全球市場佔有率（%）（依地區），2023年

腎交感神經阻斷術是一種微創手術，目的是減少腎臟的交感神經活動。導管穿過動脈直至到達腎動脈，腎動脈供應腎臟血液。然後它向血管壁中的神經提供能量，以破壞導致高血壓的訊號。能量可以透過多種方式傳遞，包括射頻消融術、超音波以及最近基於直接注射化學品和經皮傳遞系統的新技術。腎交感神經阻斷術的基本原則源自於對腎臟在調節血壓中扮演重要角色的認知。腎神經的過度活化導致全身血壓升高。透過阻斷這些過度活躍的神經途徑，腎交感神經阻斷術可能有助於持續降低其他治療方法無效的患者的血壓。儘管這種治療方法在早期臨床試驗中顯示出了希望，但隨後的幾項臨床試驗卻得出了不同的結果。儘管如此，這種醫療設備仍在繼續研究和開發，目前進行臨床試驗以評估其安全性和有效性。

市場動態：

預計去腎交感神經阻斷術裝置市場在預測期內（2023-2030年）將顯著成長。有幾個因素促進了市場的成長，包括高血壓盛行率的上升。此外，創新產品的核准增加預計也將在預測期內推動市場成長。例如，醫療設備公司 Kalos Medical 獲得了 467 萬韓元（約 350 萬美元）的津貼，用於推進治療高血壓的去腎交感神經阻斷術醫療設備的開發。

本研究的主要特點

這份研究報告對全球腎交感神經阻斷術裝置市場進行了詳細分析，包括市場規模（單位：百萬美國），以2022年為基準年的預測期（2023-2030年）的年複合成長率等。
強調了各個細分市場的潛在收益成長機會，並為該市場說明了一系列有吸引力的投資提案。
提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、業績和策略等參數對全球腎交感神經阻斷術設備市場的主要企業進行了介紹。
本研究涵蓋的主要企業包括Medtronic、Recor Medical、Boston Scientific Corp、Kona Medical、Terumo Corporation、Abbott和 Ablative Solutions。
本報告的見解將使公司行銷人員和負責人能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球腎交感神經阻斷術設備市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球腎交感神經阻斷術設備市場的各種策略矩陣來促進他們的決策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023/2024:	US$ 903.9 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR:	14.50%	2030/2031 Value Projection:	US$ 2,332.1 Mn

Renal denervation is a minimally invasive procedure that aims to decrease the sympathetic nerve activity to the kidneys. It involves threading a catheter through the arteries until it reaches the renal arteries, which supplies blood to the kidneys. The device then delivers energy to the nerves in the vessel wall to disrupt the signals that can cause high blood pressure. The energy can be delivered through various methods, such as radiofrequency ablation, ultrasound, and more recently, direct injection of chemicals or new methodologies based on percutaneous delivery systems. The rationale behind renal denervation comes from the understanding that the kidneys play a significant role in blood pressure regulation. Overactive renal nerves can lead to increased systemic blood pressure. By disrupting these overactive nerve pathways, renal denervation can potentially help to sustainably lower blood pressure in people for whom other treatments have failed. Although the procedure showed promise in early clinical trials, some subsequent trials had mixed results, which led to further investigations to better understand the patient populations that may benefit and to optimize the technique. Nonetheless, the devices continue to be studied and developed, with ongoing clinical trials evaluating their safety and efficacy.

Market Dynamics:

The renal denervation devices market is expected to witness significant growth during the forecast period (2023-2030). Several factors contribute to the market growth including the rising prevalence of hypertension. Additionally, the increasing approval of innovative products is expected to propel the market growth over the forecast period. For instance, Kalos Medical, a medical device company, received a grant of Won4.67m (approximately $3.5m) to advance the development of its renal denervation medical device to treat hypertension.

Key Features of the Study:

This report provides an in-depth analysis of the global renal denervation devices market, including market size (in US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), with 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
Key players in the global renal denervation devices market are profiled based on parameters such as company highlights, product portfolio, key highlights, financial performance, and strategies
Key companies covered in this study include Medtronic, Recor Medical, Inc., Boston Scientific Corp, Kona Medical, Terumo Corporation, Abbott, Ablative Solutions, and others
Insights from this report would enable marketers and management authorities of companies to make informed decisions regarding future product launches, product upgrades, market expansion, and marketing tactics.
The global renal denervation devices market report caters to various stakeholders in the industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global renal denervation devices market

Renal Denervation Devices Market Segmentation

By Procedure Type
- Percutaneous Renal Denervation
- Radiofrequency Renal Denervation
- Ultrasound Renal Denervation
- Others
By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Top Companies in the Renal Denervation Devices Market
- Medtronic
- Recor Medical, Inc
- Boston Scientific Corp
- Kona Medical
- Terumo Corporation
- Abbott
- Ablative Solutions
- Others

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Procedure Type
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing prevalence of acute compartment syndrome
Technological Advancement
- Restraints
Complex Regulatory Framework
- Opportunities
Untapped Potential in the Emerging Economies
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Renal Denervation Devices Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Renal Denervation Devices Market , By Procedure Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Percutaneous Renal Denervation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Radiofrequency Renal Denervation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Ultrasound Renal Denervation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Global Renal Denervation Devices Market , By End User, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

7. Global Renal Denervation Devices Market, By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2018 - 2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
China
Japan
India
Australia
ASEAN
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2018-2030,(US$ Mn)
South Africa
Central Africa
North Africa

8. Competitive Landscape

Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Recor Medical, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Boston Scientific Corp
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Kona Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Ablative Solutions
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Others
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views